Ryzodeg Penfill, Injektionslösung

7680626270013 CH-62627 Injektionslösung

Associated product:

RYZODEG Penfill sol inj 5 cartouche 3 ml
Ryzodeg Penfill, Injektionslösung
Ryzodeg Penfill, Injektionslösung
Ryzodeg Penfill, Injektionslösung
1 / 3
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/04/2023
Patient information leaflet
Français
24/04/2023
Patient information leaflet
Italien
24/04/2023
Summary of Product Characteristics
Allemand
24/04/2023
Summary of Product Characteristics
Français
24/04/2023
Summary of Product Characteristics
Italien
24/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
420.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
70.0 U Substance Wirkstoff (Principe actif)
(N/A)
180.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
30.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.5 MG Substance Konservierungsstoff (Conservateur)
(N/A)
1.72 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 89.90
Specialties list
Yes
Generic
No
SL addition date: 01/11/2013

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
62627
Drug name
Ryzodeg Penfill, Injektionslösung
Galenic form
LSPA
ATC Code
A10AD06
Authorization status
Z
Dispensing category
B
First authorization
12/09/2013
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
RYZODEG Penfill sol inj 5 cartouche 3 ml
Description (DE)
RYZODEG Penfill Inj Lös 5 Patrone 3 ml
Market launch
12/09/2013
Narcotic (BTM)
No